David Gail > Weil, Gotshal & Manges LLP > Dallas, United States > Lawyer Profile
Weil, Gotshal & Manges LLP Offices
Weil, Gotshal & Manges LLP
200 CRESCENT COURT, SUITE 300
DALLAS, TX 75201-6950
TEXAS
United States
200 CRESCENT COURT, SUITE 300
DALLAS, TX 75201-6950
TEXAS
United States
- Firm Profile
- Go to...
David Gail
1 214 746 7786 [email protected]
Position
Partner
Career
David Gail is a partner in Weil’s Private Equity practice, where he advises private equity sponsors and their portfolio companies in a wide variety of transactions, including leveraged buyouts, mergers and acquisitions, strategic investments, restructurings, financings and dispositions. David also advises clients on general corporate and commercial matters. His clients include PSG Equity, Providence Equity Partners, Kainos Capital, Lindsay Goldberg and Graycliff Partners, as well as their portfolio companies.
Education
Princeton University (B.A., cum laude, 2003); Southern Methodist University Law (J.D., magna cum laude, 2008).
Top Tier Firm Rankings
- Finance > Capital markets: debt offerings
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Finance > Restructuring (including bankruptcy): corporate
- Media, technology and telecoms > Technology transactions
- Tax > US taxes: non-contentious
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: equity offerings
- Intellectual property > Copyright
- Tax > Financial products
- Media, technology and telecoms > Media and entertainment: litigation
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Industry focus > Sport
- Finance > Structured finance: securitization
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: oil and gas
- Labor and employment > Labor and employment disputes (including collective actions)
- Healthcare > Life sciences
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trademarks: litigation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense